Protocol summary

Study aim
Investigating the effect of ultrasound- guided bilateral dual transverse abdominal plane block (TAP) and erector spine plane block on the postoperative quality of recovery after total abdominal hysterectomy
Design
Clinical trial with control group, parallel groups, double-blind, randomized, phase 3 on 40 patients. In order to randomize, the block randomization method will be used.
Settings and conduct
In this research, all patients requiring total abdominal hysterectomy surgery, referred to Firouzgar and Rasoul Akram Hospitals in Tehran, will be included in the study.Patients will be randomly divided into 2 groups based on blocks of 6. The sample size for each study group is 30 people. A total of 60 patients will be examined. Patients, surgeon and data analyst will be blinded.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Women with uterine diseases and candidates for full abdominal hysterectomy Age between 20-60 years A person with normal health A person with mild systemic disease Non-entry criteria: Allergy to any of the drugs used in the study Addiction to alcohol, benzodiazepines and narcotics The presence of underlying diseases including kidney disease, liver disease, heart failure, arrhythmia or valvular heart disease Coagulation disorder Contraindications for regional anesthesia Emergency patients Patients who have received analgesics in the last 24 hours
Intervention groups
Intervention group 1: In patients with bilateral erector spinae plate block, at the T9 level of the lumbar vertebra, 20 cc of ropivacaine 0.2% will be used bilaterally. Intervention group 2: In the bilateral dual transverse abdominal plane block (TAP) group, on each side two injections, one in the umbilical alignment and the other subcostal, 15 cc of ropivacaine 0.2% will be used.
Main outcome variables
Severity of patients' pain

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20230424057986N2
Registration date: 2023-06-08, 1402/03/18
Registration timing: prospective

Last update: 2023-06-08, 1402/03/18
Update count: 0
Registration date
2023-06-08, 1402/03/18
Registrant information
Name
Saghar Ansari
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2255 9577
Email address
ansarisaghar@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-06-27, 1402/04/06
Expected recruitment end date
2023-11-22, 1402/09/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the effect of ultrasound- guided bilateral dual transverse abdominal plane block (TAP) and erector spine plane block on the postoperative quality of recovery after total abdominal hysterectomy
Public title
Investigating the effect of ultrasound- guided bilateral dual TAP block and erector spine plane block
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Women with uterine diseases and candidates for full abdominal hysterectomy Age between 20-60 years A person with normal health A person with mild systemic disease
Exclusion criteria:
Allergy to any of the drugs used in the study Addiction to alcohol, benzodiazepines and narcotics The presence of underlying diseases including kidney disease, liver disease, heart failure, arrhythmia or valvular heart disease. Coagulation disorder Contraindications for regional anesthesia Emergency patients Patients who have received analgesics in the last 24 hours
Age
From 20 years old to 60 years old
Gender
Female
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
Patients will be randomly divided into two groups. The randomization tool will be a random sequence generation software called SAS. In addition to simple randomization, these random sequence generation software are capable of generating random sequence by block method. Block randomization method will be used for randomization. Block randomization is for the purpose of making sure that exactly equal number of participants enter the study groups. The advantages of block randomization are that the balance of the number of participants in each group is guaranteed. For this purpose, 6 blocks will be formed and in each block, 3 people from first intervention group and 3 people in second intervention group will be placed. A total of 10 blocks will be considered to reach the sample size. The blocks contain numbers, odd numbers represent the first intervention group and even numbers represent the second intervention group. Their order will be determined by the software initially. In order to hide the random allocation, opaque envelopes sealed with a random sequence will be used. In this method, each of the generated random sequences will be recorded on a card and the cards respectively will be placed in the envelopes. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of registration of participants, based on the order of entry of qualified participants into the study, one of the envelopes will be opened in order and the assigned group of that participant will be revealed.
Blinding (investigator's opinion)
Double blinded
Blinding description
Patients will be blinded to the type of block. Patients will be aware that they will be randomly assigned to one of the two treatment groups, but will not know which block will be provided in that group. Patients will be assigned to one of two groups using a random number table. The person in charge of data collection, the analyst and the outcome evaluator will collect and analyze the data based on groups 1 and 2 and will not know the type of treatment provided in the groups and will be kept blind.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Approval date
2023-04-16, 1402/01/27
Ethics committee reference number
IR.IUMS.FMD.REC.1402.025

Health conditions studied

1

Description of health condition studied
Pain
ICD-10 code
G89
ICD-10 code description
Pain

Primary outcomes

1

Description
Severity of patients' pain
Timepoint
1, 2, 4, 8, 12 and 24 hours after surgery
Method of measurement
Based on visual analog scale

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: In patients with bilateral erector spinae plate block, at the T9 level of the lumbar vertebra, 20 cc of ropivacaine 0.2% will be used bilaterally (5 mg/ml) (manufacturer: Ropivacaine Molteni) (40 cc of ropivacaine 0.2% in total). The ultrasound probe used in this group will be a curve probe in a lateral position.
Category
Treatment - Other

2

Description
Intervention group: In the bilateral dual transverse abdominal plane block (TAP) group, on each side two injections, one in the umbilical alignment and the other subcostal, 15 cc of ropivacaine 0.2% (5 mg/ml) (manufacturer: Ropivacaine Molteni) (total 60 CC ropivacaine 0.2%) will be used. The ultrasound probe used in this group will be a linear probe in the supine position.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Rasoul-Akram Hospital
Full name of responsible person
Saghar Ansari
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
تهران
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2222
Email
Rasoolhospital@iums.ac.ir

2

Recruitment center
Name of recruitment center
Firouzgar hospital
Full name of responsible person
Saghar Ansari
Street address
Beh Afarin Ave, Vali Asr Sq.
City
Tehran
Province
Tehran
Postal code
1593747811
Phone
+98 21 8214 1600
Email
h_firoozgar@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Hossein Keyvani
Street address
Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8670 2503
Email
research@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Hamid Reza Feiz
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6435 2559
Email
hrfaiz@hotmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Hamid Reza Feiz
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 2255 9577
Email
hrfaiz@hotmail.com

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Saghar Ansari
Position
Resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Rasoul-Akram Hospital, Niayesh St., Sattarkahn Ave
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 2255 9577
Email
ansarisaghar@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...